INSILICO MEDICINE

insilico-medicine-logo

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. It pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning, and meta-learning for the generation of novel molecular structures for the diseases with known and unknown targets, and, unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis, and digita... l medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.

#SimilarOrganizations #People #Financial #Event #Website #More

INSILICO MEDICINE

Social Links:

Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical

Founded:
2014-01-01

Address:
Hong Kong, Hong Kong Island, Hong Kong

Country:
Hong Kong

Website Url:
http://www.insilico.com

Total Employee:
101+

Status:
Active

Email Addresses:
ai@insilico.com

Total Funding:
401.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Euro COVID-19


Similar Organizations

3billion-logo

3billion

3billion is a world leader in the field of genetic diagnostics for rare disease.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

helixnano-logo

HelixNano

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

fabric-genomics-formerly-omicia-logo

Fabric Genomics (formerly Omicia)

Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

kristen-fortney_image

Kristen Fortney Scientific Advisor @ Insilico Medicine
Advisor
2014-01-01

min-fang_image

Min Fang Board Member @ Insilico Medicine
Board_member

nisa-leung_image

Nisa Leung Board Member @ Insilico Medicine
Board_member

garri-zmudze_image

Garri Zmudze Business Advisor @ Insilico Medicine
Advisor
2016-04-01

Current Employees Featured

alex-zhavoronkov_image

Alex Zhavoronkov
Alex Zhavoronkov Founder & Chief Executive Officer @ Insilico Medicine
Founder & Chief Executive Officer
2014-03-01

qingsong-zhu_image

Qingsong Zhu
Qingsong Zhu COO @ Insilico Medicine
COO
2014-01-01

michelle-chen_image

Michelle Chen
Michelle Chen Chief Business Officer @ Insilico Medicine
Chief Business Officer
2021-10-01

robert-spiegel_image

Robert Spiegel
Robert Spiegel Chief Medical Officer @ Insilico Medicine
Chief Medical Officer
2021-09-01

alex-aliper_image

Alex Aliper
Alex Aliper President of EMEA @ Insilico Medicine
President of EMEA
2015-12-01

vladimir-naumov_image

Vladimir Naumov
Vladimir Naumov bioinformatics data scientist @ Insilico Medicine
bioinformatics data scientist
2020-04-01

not_available_image

Nirav Jhaveri
Nirav Jhaveri Chief Financial Officer @ Insilico Medicine
Chief Financial Officer
2021-01-01

feng-ren_image

Feng Ren
Feng Ren co-CEO @ Insilico Medicine
co-CEO
2022-06-01

polina-mamoshina_image

Polina Mamoshina
Polina Mamoshina Research Scientist @ Insilico Medicine
Research Scientist

Founder


alex-zhavoronkov_image

Alex Zhavoronkov

Investors List

b-capital-group_image

B Capital Group

B Capital Group investment in Series D - Insilico Medicine

bhr-partners_image

BHR Partners

BHR Partners investment in Series D - Insilico Medicine

prosperity7-ventures-d527_image

Prosperity7 Ventures

Prosperity7 Ventures investment in Series D - Insilico Medicine

wilson-sonsini-goodrich-rosati_image

Wilson Sonsini Goodrich & Rosati

Wilson Sonsini Goodrich & Rosati investment in Series D - Insilico Medicine

deerfield_image

Deerfield

Deerfield investment in Series D - Insilico Medicine

pavilion-capital_image

Pavilion Capital

Pavilion Capital investment in Series D - Insilico Medicine

warburg-pincus_image

Warburg Pincus

Warburg Pincus investment in Series D - Insilico Medicine

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series D - Insilico Medicine

bold-capital_image

Bold Capital Partners

Bold Capital Partners investment in Series D - Insilico Medicine

bold-capital_image

Bold Capital Partners

Bold Capital Partners investment in Series D - Insilico Medicine

Newest Events participated

nips-2018_event_image Participated in NIPS 2018 on 2018-12-03 as sponsor

women-in-machine-learning-dinner-london-2018_event_image Participated in Women in Machine Learning Dinner London 2018 on 2018-11-20 as sponsor

women-in-ai-in-healthcare-dinner-london-2017_event_image Participated in Women in AI in Healthcare Dinner, London 2017 on 2017-11-22 as sponsor

biodata-west_event_image Participated in BioData West on 2017-10-10 as sponsor

Official Site Inspections

http://www.insilico.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.88 K

  • Host name: 185.215.4.66
  • IP address: 185.215.4.66
  • Location: Denmark
  • Latitude: 55.7123
  • Longitude: 12.0564
  • Timezone: Europe/Copenhagen

Loading ...

More informations about "Insilico Medicine"

Insilico Medicine - Wikipedia

Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. See details»

Insilico - Crunchbase Company Profile & Funding

Insilico is a company that provides new material development and system construction services with a new high-efficiency/low-cost methodology based on IT and material convergence technology. The company also provides …See details»

Team | Insilico Medicine

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in generative artificial intelligence technologies for drug discovery and biomarker development.Dr. Zhavoronkov has a combined …See details»

Insilico Medicine - Crunchbase Company Profile

Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life …See details»

Mission | Insilico Medicine

The company's team is distributed globally, allowing the company to establish a local presence in key geographies, with office sites or R&D talents in the U.S., Greater China, Canada, and the Middle East to support recruitment of top …See details»

InSilico Medicine Company Profile 2025: Valuation, …

InSilico Medicine General Information Description. Researcher and developer of an artificial intelligence (AI) platform and new drugs designed to deliver breakthrough solutions for cancer, fibrosis, immunity, central nervous system …See details»

Insilico Medicine | World Economic Forum

Dec 20, 2023 The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders of society to shape global, …See details»

Insilico Medicine - Overview, News & Similar companies - ZoomInfo

May 30, 2024 Insilico developed a PaperGPT system based on ChatGPT-4 Turbo and internal LLM that provides answers related to the paper via chat functionality. NEW YORK and HONG …See details»

insilicogroup.com – Innovate, Scale & Thrive

With an unwavering commitment to excellence, InSilico stands ready to redefine possibilities and empower businesses for a prosperous future. 01 Tech-Driven Business Strategy. 02 Mobile …See details»

Insilico Medicine Company Profile: AI, Investments, Contact …

Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company …See details»

Insilico Medicine - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»

InSilico Medicine Company Profile - Office Locations ... - Craft

InSilico Medicine Hong Kong is a technology company that develops AI-based platforms for drug development and discovery. It provides Pharma.AI, a drug discovery engine that utilizes data …See details»

Insilico - Lab Manager

As a result, Insilco’s unique approach substantially reduces experimental effort, costs of goods and time to market. Leading biopharmaceutical companies worldwide use Insilico digital twins …See details»

Working At Insilico Medicine: Company Overview and Culture

Mar 14, 2024 Insilico Medicine, an artificial intelligence company headquartered in Rockville, MD, pioneered the applications of the generative adversarial networks (GANs), reinforcement …See details»

Insilico Medicine launches a 6th generation Intelligent Robotics …

Jan 5, 2023 Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life Star – a 6th generation Intelligent …See details»

20 Things You Didn’t Know About Insilico Medicine - Money Inc

Oct 13, 2021 NVIDIA named Insilico to its list of the top five artificial intelligence companies in 2017. The organization cited that Insilico has a tremendous potential to make a positive social …See details»

Insilico's AI-Designed Drug ISM5411 Shows Promise

14 hours ago CAMBRIDGE, Massachusetts, Jan 7, 2024 — Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development …See details»

Chemistry42 - Insilico

Chemistry42 is a comprehensive small molecules drug discovery platform. It streamlines hit identification, hit-to-lead, and lead optimization programs.See details»

Press Releases | Insilico Medicine

Jan 10, 2023 1250 René-Lévesque Ouest, Suite 3710, Montréal, Québec, Canada H3B 4W8See details»

Insilico Reports Promising Topline Results from Two Phase 1 Trials of

13 hours ago Insilico Medicine, a trailblazer in the realm of artificial intelligence (AI)-driven drug discovery, has announced promising outcomes from two Phase I clinical trials of ISM5411, a …See details»

linkstock.net © 2022. All rights reserved